Charles Sparks
Concepts (365)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Apolipoproteins B | 44 | 1981 | 18 |
Why?
| Myocardial Infarction | 17 | 1999 | 129 |
Why?
| Liver | 40 | 1979 | 249 |
Why?
| Insulin | 25 | 1986 | 129 |
Why?
| Lipoproteins, VLDL | 22 | 1976 | 7 |
Why?
| Lipoproteins | 16 | 1979 | 52 |
Why?
| Cholesterol, HDL | 6 | 2003 | 26 |
Why?
| Polymorphism, Genetic | 5 | 2007 | 94 |
Why?
| Metabolic Syndrome X | 4 | 2003 | 34 |
Why?
| Triglycerides | 16 | 1979 | 48 |
Why?
| Obesity | 7 | 1991 | 149 |
Why?
| Hypertriglyceridemia | 5 | 1996 | 14 |
Why?
| C-Reactive Protein | 8 | 2002 | 55 |
Why?
| Coronary Disease | 3 | 2004 | 94 |
Why?
| Apolipoproteins | 17 | 1978 | 19 |
Why?
| Rats | 54 | 1976 | 532 |
Why?
| Recurrence | 13 | 1999 | 261 |
Why?
| Inflammation | 4 | 2005 | 208 |
Why?
| Phospholipases A | 2 | 2006 | 24 |
Why?
| Carrier Proteins | 3 | 1996 | 177 |
Why?
| Proportional Hazards Models | 10 | 2000 | 123 |
Why?
| Blood Glucose | 7 | 1994 | 99 |
Why?
| Male | 59 | 1976 | 1558 |
Why?
| Cholesterol Ester Transfer Proteins | 2 | 2010 | 9 |
Why?
| Hepatocytes | 2 | 2002 | 42 |
Why?
| Animals | 61 | 1976 | 1032 |
Why?
| Diabetes Mellitus | 2 | 2001 | 73 |
Why?
| Risk Factors | 13 | 1999 | 557 |
Why?
| Rats, Zucker | 6 | 1994 | 7 |
Why?
| Plasminogen Activator Inhibitor 1 | 3 | 1999 | 26 |
Why?
| Lipase | 3 | 1983 | 11 |
Why?
| RNA, Messenger | 12 | 1990 | 394 |
Why?
| Apolipoprotein A-I | 3 | 1981 | 19 |
Why?
| Biological Markers | 7 | 2005 | 263 |
Why?
| Receptors, LDL | 3 | 1985 | 14 |
Why?
| Coronary Artery Disease | 2 | 2005 | 56 |
Why?
| Betaine-Homocysteine S-Methyltransferase | 3 | 1999 | 4 |
Why?
| Lipoprotein(a) | 2 | 1991 | 12 |
Why?
| Hypercholesterolemia | 3 | 1986 | 33 |
Why?
| Rats, Sprague-Dawley | 11 | 1993 | 257 |
Why?
| Forkhead Transcription Factors | 1 | 2008 | 44 |
Why?
| Cholesterol | 10 | 1979 | 86 |
Why?
| Interleukin-6 | 1 | 2010 | 146 |
Why?
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2007 | 5 |
Why?
| Diabetic Angiopathies | 1 | 2007 | 24 |
Why?
| NADPH Oxidase | 1 | 2007 | 21 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2007 | 40 |
Why?
| Middle Aged | 15 | 1999 | 1166 |
Why?
| Lipids | 9 | 1988 | 98 |
Why?
| Cells, Cultured | 19 | 1986 | 447 |
Why?
| Insulin Resistance | 3 | 1994 | 37 |
Why?
| Female | 22 | 1986 | 1646 |
Why?
| Diabetes Mellitus, Type 2 | 3 | 2000 | 78 |
Why?
| Humans | 35 | 1976 | 1858 |
Why?
| Lipoproteins, HDL | 9 | 1979 | 21 |
Why?
| Coronary Vessels | 1 | 2005 | 53 |
Why?
| Diabetes Mellitus, Experimental | 5 | 1988 | 36 |
Why?
| Multivariate Analysis | 6 | 2000 | 227 |
Why?
| Lipoproteins, LDL | 10 | 1976 | 20 |
Why?
| Hyperinsulinism | 3 | 1996 | 10 |
Why?
| Genetic Predisposition to Disease | 4 | 2005 | 132 |
Why?
| Nephrosis | 4 | 1979 | 1 |
Why?
| von Willebrand Factor | 2 | 1999 | 34 |
Why?
| Cardiovascular Diseases | 3 | 2005 | 127 |
Why?
| Methyltransferases | 2 | 1999 | 18 |
Why?
| Oleic Acid | 4 | 1981 | 14 |
Why?
| Blood Proteins | 5 | 1976 | 71 |
Why?
| Sex Characteristics | 2 | 2000 | 86 |
Why?
| Dietary Fats | 1 | 2000 | 33 |
Why?
| RNA Editing | 5 | 1993 | 10 |
Why?
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2006 | 10 |
Why?
| Hyperglycemia | 2 | 1988 | 31 |
Why?
| Liver Neoplasms, Experimental | 2 | 1996 | 21 |
Why?
| Serum Amyloid A Protein | 3 | 2002 | 15 |
Why?
| Stearic Acids | 1 | 1997 | 7 |
Why?
| Diltiazem | 2 | 1985 | 15 |
Why?
| Mice | 5 | 2002 | 623 |
Why?
| Chromatography, Agarose | 2 | 1979 | 5 |
Why?
| Blood Chemical Analysis | 2 | 1990 | 34 |
Why?
| Genotype | 3 | 2005 | 175 |
Why?
| Cyclopentanes | 2 | 1992 | 6 |
Why?
| Androstadienes | 2 | 1996 | 25 |
Why?
| Phospholipases A2 | 2 | 2006 | 16 |
Why?
| Probability | 3 | 2003 | 190 |
Why?
| Survival Analysis | 3 | 2005 | 206 |
Why?
| Risk Assessment | 4 | 2003 | 325 |
Why?
| Angina, Unstable | 2 | 2005 | 20 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1996 | 19 |
Why?
| Phenotype | 3 | 2000 | 304 |
Why?
| Aged | 7 | 1999 | 992 |
Why?
| Phosphatidylinositol 3-Kinases | 3 | 1996 | 67 |
Why?
| Pyridinium Compounds | 2 | 1991 | 8 |
Why?
| Electrophoresis, Polyacrylamide Gel | 7 | 1981 | 168 |
Why?
| Chromatography, Gel | 5 | 1981 | 61 |
Why?
| Sensitivity and Specificity | 3 | 1990 | 427 |
Why?
| Kaplan-Meier Estimate | 3 | 2008 | 90 |
Why?
| Follow-Up Studies | 5 | 2000 | 554 |
Why?
| Hepatectomy | 1 | 1994 | 24 |
Why?
| Enzyme Inhibitors | 2 | 1996 | 216 |
Why?
| Kinetics | 13 | 1979 | 349 |
Why?
| Methionine | 4 | 1986 | 38 |
Why?
| Chi-Square Distribution | 3 | 2002 | 179 |
Why?
| Fluorescent Dyes | 2 | 1991 | 115 |
Why?
| Gene Frequency | 2 | 2010 | 42 |
Why?
| Lipoprotein Lipase | 2 | 1984 | 4 |
Why?
| Rats, Inbred Strains | 11 | 1986 | 170 |
Why?
| Odds Ratio | 2 | 2001 | 157 |
Why?
| Adult | 7 | 1987 | 1321 |
Why?
| Up-Regulation | 2 | 2010 | 183 |
Why?
| Diabetes Mellitus, Type 1 | 2 | 2001 | 58 |
Why?
| Time Factors | 5 | 1983 | 896 |
Why?
| Mice, Mutant Strains | 1 | 2011 | 77 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 9 |
Why?
| Intestines | 3 | 1981 | 83 |
Why?
| Adenoviridae | 1 | 2011 | 60 |
Why?
| Cohort Studies | 3 | 2005 | 333 |
Why?
| Genetic Testing | 2 | 2005 | 49 |
Why?
| Reference Values | 2 | 1990 | 281 |
Why?
| Tumor Cells, Cultured | 5 | 1996 | 233 |
Why?
| Apolipoproteins C | 3 | 1981 | 4 |
Why?
| Angina Pectoris | 1 | 2008 | 31 |
Why?
| Molecular Weight | 6 | 1979 | 155 |
Why?
| Fatty Liver | 1 | 2008 | 20 |
Why?
| Fibrosis | 1 | 2008 | 46 |
Why?
| Prospective Studies | 4 | 1999 | 547 |
Why?
| Genetic Markers | 1 | 2007 | 78 |
Why?
| Transfection | 1 | 2011 | 237 |
Why?
| Bilirubin | 1 | 1987 | 29 |
Why?
| Liver Diseases | 1 | 1987 | 56 |
Why?
| Cytidine Deaminase | 2 | 1996 | 15 |
Why?
| Cholesterol, VLDL | 1 | 2006 | 2 |
Why?
| Growth and Development | 1 | 2006 | 4 |
Why?
| Sterol Regulatory Element Binding Proteins | 1 | 2006 | 4 |
Why?
| Betaine | 1 | 2006 | 6 |
Why?
| Iodoproteins | 1 | 1986 | 1 |
Why?
| Amino Acid Substitution | 1 | 2007 | 68 |
Why?
| Pregnancy, Animal | 1 | 1986 | 20 |
Why?
| Postpartum Period | 1 | 1986 | 32 |
Why?
| Enzyme Induction | 1 | 2006 | 64 |
Why?
| Mammary Glands, Animal | 1 | 1986 | 14 |
Why?
| Case-Control Studies | 1 | 2007 | 284 |
Why?
| Apolipoproteins E | 4 | 1981 | 26 |
Why?
| Prognosis | 3 | 2000 | 389 |
Why?
| Benzazepines | 1 | 1985 | 12 |
Why?
| Protein Biosynthesis | 3 | 1988 | 113 |
Why?
| Fasting | 2 | 1982 | 41 |
Why?
| Lipolysis | 1 | 1984 | 5 |
Why?
| Diet | 1 | 2006 | 87 |
Why?
| Young Adult | 1 | 2008 | 381 |
Why?
| Risk | 1 | 2005 | 203 |
Why?
| RNA Stability | 1 | 2006 | 38 |
Why?
| Gene Expression Regulation | 1 | 2010 | 279 |
Why?
| Blood Coagulation Factors | 2 | 2000 | 31 |
Why?
| Body Mass Index | 1 | 2005 | 122 |
Why?
| Factor Analysis, Statistical | 1 | 2003 | 45 |
Why?
| Biological Transport | 2 | 1993 | 129 |
Why?
| Reproducibility of Results | 1 | 2007 | 392 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2006 | 119 |
Why?
| Prevalence | 1 | 2005 | 282 |
Why?
| Oxidative Stress | 1 | 2007 | 119 |
Why?
| Models, Biological | 1 | 2008 | 411 |
Why?
| Rats, Inbred F344 | 4 | 1981 | 80 |
Why?
| Convalescence | 1 | 2001 | 15 |
Why?
| Base Sequence | 5 | 1990 | 371 |
Why?
| Apolipoproteins A | 1 | 1981 | 9 |
Why?
| Disease Progression | 1 | 2004 | 244 |
Why?
| Transcription, Genetic | 1 | 2006 | 253 |
Why?
| Antibodies, Monoclonal | 1 | 1986 | 242 |
Why?
| DNA, Complementary | 2 | 1997 | 139 |
Why?
| Carcinoma, Hepatocellular | 1 | 1981 | 53 |
Why?
| Fatty Acids | 4 | 1979 | 48 |
Why?
| Flow Cytometry | 3 | 1991 | 216 |
Why?
| Netherlands | 2 | 2010 | 16 |
Why?
| Thrombosis | 2 | 1999 | 105 |
Why?
| Sodium Dodecyl Sulfate | 2 | 1981 | 13 |
Why?
| Apolipoprotein B-48 | 2 | 1996 | 3 |
Why?
| Apolipoprotein B-100 | 2 | 1996 | 5 |
Why?
| Aging | 1 | 2006 | 275 |
Why?
| Nephrotic Syndrome | 1 | 1979 | 16 |
Why?
| Enzyme Activation | 2 | 1996 | 177 |
Why?
| Hyperlipidemias | 1 | 2000 | 42 |
Why?
| Hypertension | 1 | 2003 | 161 |
Why?
| Hydrolysis | 2 | 1978 | 57 |
Why?
| Brefeldin A | 2 | 1992 | 6 |
Why?
| Molecular Sequence Data | 4 | 1990 | 404 |
Why?
| Hemostasis | 1 | 1999 | 44 |
Why?
| Postprandial Period | 1 | 1998 | 14 |
Why?
| Glucose | 1 | 2000 | 120 |
Why?
| Disease Models, Animal | 2 | 1996 | 349 |
Why?
| Organ Size | 1 | 1998 | 118 |
Why?
| Puromycin Aminonucleoside | 3 | 1979 | 1 |
Why?
| Amino Acids | 3 | 1981 | 108 |
Why?
| Enzymes | 1 | 1998 | 22 |
Why?
| Ethanol | 1 | 1998 | 58 |
Why?
| Serum Albumin | 3 | 1976 | 55 |
Why?
| Cyclic AMP | 3 | 1992 | 90 |
Why?
| Blood Coagulation | 1 | 1998 | 57 |
Why?
| Body Weight | 1 | 1998 | 178 |
Why?
| Protein Tyrosine Phosphatases | 1 | 1997 | 27 |
Why?
| Thromboplastin | 1 | 1998 | 21 |
Why?
| Endoplasmic Reticulum | 1 | 1997 | 59 |
Why?
| Mice, Inbred C57BL | 1 | 2002 | 318 |
Why?
| Endothelium, Vascular | 1 | 2001 | 139 |
Why?
| New York | 1 | 2001 | 425 |
Why?
| Radioimmunoassay | 2 | 1986 | 82 |
Why?
| Smoking | 1 | 2000 | 153 |
Why?
| Gold Colloid | 1 | 1996 | 6 |
Why?
| Culture Media | 2 | 1988 | 116 |
Why?
| Precipitin Tests | 1 | 1996 | 81 |
Why?
| Coloring Agents | 1 | 1996 | 42 |
Why?
| Receptors, Cell Surface | 1 | 1997 | 115 |
Why?
| Lipid Metabolism | 2 | 1992 | 50 |
Why?
| Microscopy, Electron | 2 | 1991 | 178 |
Why?
| Amino Acid Sequence | 1 | 1999 | 319 |
Why?
| Protein Binding | 2 | 1985 | 256 |
Why?
| Liver Regeneration | 1 | 1994 | 8 |
Why?
| Thyroid Hormones | 1 | 1994 | 23 |
Why?
| Staining and Labeling | 2 | 1991 | 101 |
Why?
| Lung | 2 | 1976 | 233 |
Why?
| Chylomicrons | 2 | 1981 | 3 |
Why?
| Epidermal Growth Factor | 1 | 1994 | 51 |
Why?
| Acetates | 2 | 1988 | 19 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 1994 | 62 |
Why?
| Peptide Chain Elongation, Translational | 1 | 1992 | 7 |
Why?
| Temperature | 1 | 1993 | 137 |
Why?
| Pancreatic Hormones | 1 | 1992 | 4 |
Why?
| Prostaglandins | 1 | 1992 | 41 |
Why?
| RNA-Binding Proteins | 1 | 1993 | 55 |
Why?
| Molecular Structure | 1 | 1991 | 67 |
Why?
| Phospholipids | 3 | 1979 | 52 |
Why?
| Weight Loss | 1 | 1991 | 52 |
Why?
| Glucagon | 3 | 1992 | 31 |
Why?
| Cell Line | 3 | 1981 | 375 |
Why?
| Homozygote | 1 | 2010 | 68 |
Why?
| Spectrometry, Fluorescence | 1 | 1991 | 59 |
Why?
| Sulfur Radioisotopes | 1 | 1990 | 24 |
Why?
| Geography | 1 | 2010 | 18 |
Why?
| Blood Specimen Collection | 1 | 1990 | 17 |
Why?
| Immunoassay | 1 | 1990 | 33 |
Why?
| Medical Laboratory Science | 1 | 1990 | 9 |
Why?
| Punctures | 1 | 1990 | 22 |
Why?
| False Positive Reactions | 1 | 1990 | 71 |
Why?
| Calibration | 1 | 1990 | 37 |
Why?
| Spectrophotometry | 1 | 1990 | 54 |
Why?
| Allied Health Personnel | 1 | 1990 | 16 |
Why?
| Lymphocytes | 1 | 1991 | 142 |
Why?
| Veins | 1 | 1990 | 41 |
Why?
| Atherosclerosis | 1 | 2010 | 29 |
Why?
| Particle Size | 1 | 2010 | 55 |
Why?
| Fingers | 1 | 1990 | 37 |
Why?
| Oligodeoxyribonucleotides | 3 | 1990 | 86 |
Why?
| Longitudinal Studies | 1 | 2010 | 195 |
Why?
| Antibodies | 1 | 1990 | 159 |
Why?
| Centrifugation, Density Gradient | 2 | 1979 | 48 |
Why?
| Factor VIIa | 2 | 1998 | 12 |
Why?
| Fibrinogen | 2 | 1999 | 45 |
Why?
| Vanadates | 1 | 1988 | 13 |
Why?
| Oleic Acids | 2 | 1981 | 13 |
Why?
| Autoanalysis | 1 | 1987 | 13 |
Why?
| Predictive Value of Tests | 1 | 1990 | 322 |
Why?
| Quality Control | 1 | 1987 | 54 |
Why?
| Perfusion | 2 | 1983 | 73 |
Why?
| Mass Screening | 1 | 1990 | 126 |
Why?
| Acetic Acid | 1 | 1986 | 10 |
Why?
| Hybridomas | 1 | 1986 | 31 |
Why?
| Acetic Acids | 1 | 1986 | 31 |
Why?
| Metabolic Clearance Rate | 1 | 2006 | 31 |
Why?
| Biological Availability | 1 | 2006 | 36 |
Why?
| Diet, Atherogenic | 1 | 1986 | 7 |
Why?
| Glycosaminoglycans | 1 | 1986 | 20 |
Why?
| Feedback | 1 | 2006 | 54 |
Why?
| Thyroid Gland | 1 | 1986 | 40 |
Why?
| Iodine Radioisotopes | 3 | 1976 | 64 |
Why?
| Epitopes | 1 | 1986 | 87 |
Why?
| Regression Analysis | 1 | 1987 | 256 |
Why?
| Calcium | 1 | 1992 | 210 |
Why?
| Trichloroacetic Acid | 1 | 1985 | 8 |
Why?
| Dialysis | 1 | 1985 | 19 |
Why?
| Chemical Precipitation | 1 | 1985 | 24 |
Why?
| Delivery of Health Care | 1 | 1987 | 102 |
Why?
| Aorta | 1 | 1986 | 69 |
Why?
| Multicenter Studies as Topic | 1 | 2005 | 70 |
Why?
| Heparin | 2 | 1976 | 87 |
Why?
| Polymerase Chain Reaction | 3 | 1990 | 279 |
Why?
| Anura | 1 | 1963 | 8 |
Why?
| Blood Protein Electrophoresis | 1 | 1963 | 13 |
Why?
| Rabbits | 2 | 1981 | 254 |
Why?
| Metamorphosis, Biological | 1 | 1963 | 4 |
Why?
| Genetic Variation | 1 | 1985 | 92 |
Why?
| Physiology | 1 | 1963 | 14 |
Why?
| Apolipoprotein C-III | 1 | 1983 | 2 |
Why?
| Apolipoprotein C-II | 1 | 1983 | 4 |
Why?
| Chemical Phenomena | 1 | 1983 | 44 |
Why?
| Protein Conformation | 1 | 1985 | 123 |
Why?
| Hemoglobins | 1 | 1963 | 74 |
Why?
| Chemistry | 1 | 1983 | 44 |
Why?
| Surface Tension | 1 | 1983 | 15 |
Why?
| Adsorption | 1 | 1983 | 37 |
Why?
| Rats, Wistar | 2 | 1992 | 75 |
Why?
| Mice, Knockout | 1 | 2006 | 265 |
Why?
| Research | 1 | 1963 | 125 |
Why?
| Serum Albumin, Bovine | 1 | 1981 | 29 |
Why?
| Lipoproteins, IDL | 1 | 1981 | 1 |
Why?
| Severity of Illness Index | 1 | 2005 | 359 |
Why?
| Oxidation-Reduction | 2 | 1992 | 124 |
Why?
| Glucose Clamp Technique | 1 | 2000 | 13 |
Why?
| Liver Neoplasms | 1 | 1981 | 97 |
Why?
| Pregnancy | 1 | 1986 | 457 |
Why?
| Dexamethasone | 1 | 2000 | 109 |
Why?
| Factor VII | 1 | 1999 | 10 |
Why?
| Fibrin Fibrinogen Degradation Products | 1 | 1999 | 16 |
Why?
| Glucocorticoids | 1 | 2000 | 108 |
Why?
| Heart Diseases | 1 | 2000 | 92 |
Why?
| Factor Va | 1 | 1998 | 4 |
Why?
| Logistic Models | 1 | 2000 | 254 |
Why?
| Insulin Receptor Substrate Proteins | 1 | 1997 | 5 |
Why?
| Blood Donors | 1 | 1998 | 19 |
Why?
| Peptide Hydrolases | 1 | 1978 | 38 |
Why?
| Factor Xa | 1 | 1998 | 10 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 1997 | 4 |
Why?
| DNA, Antisense | 1 | 1997 | 12 |
Why?
| Microsomes, Liver | 1 | 1997 | 19 |
Why?
| Cell Fractionation | 1 | 1996 | 42 |
Why?
| Phosphoproteins | 1 | 1997 | 86 |
Why?
| RNA, Neoplasm | 1 | 1996 | 41 |
Why?
| Cross-Linking Reagents | 1 | 1996 | 38 |
Why?
| Immunoblotting | 1 | 1996 | 120 |
Why?
| Cytosol | 1 | 1996 | 79 |
Why?
| Blood Platelets | 1 | 1998 | 68 |
Why?
| Dose-Response Relationship, Drug | 1 | 1998 | 431 |
Why?
| Ultraviolet Rays | 1 | 1996 | 76 |
Why?
| Forskolin | 1 | 1994 | 19 |
Why?
| Esterification | 1 | 1992 | 4 |
Why?
| 16,16-Dimethylprostaglandin E2 | 1 | 1992 | 2 |
Why?
| Organ Specificity | 1 | 1993 | 104 |
Why?
| Phycoerythrin | 1 | 1992 | 6 |
Why?
| Calcimycin | 1 | 1992 | 25 |
Why?
| Verapamil | 1 | 1992 | 19 |
Why?
| Streptozocin | 1 | 1992 | 18 |
Why?
| Golgi Apparatus | 1 | 1992 | 26 |
Why?
| Prostaglandin D2 | 1 | 1992 | 20 |
Why?
| Fluorescent Antibody Technique | 1 | 1992 | 164 |
Why?
| Homeostasis | 1 | 1992 | 99 |
Why?
| Ribosomes | 1 | 1992 | 26 |
Why?
| Oligonucleotide Probes | 1 | 1991 | 40 |
Why?
| RNA Processing, Post-Transcriptional | 1 | 1992 | 33 |
Why?
| Dinoprostone | 1 | 1992 | 55 |
Why?
| Models, Genetic | 1 | 1991 | 90 |
Why?
| Intestine, Small | 1 | 1990 | 55 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 1991 | 224 |
Why?
| Ketosis | 1 | 1988 | 3 |
Why?
| Hydrocortisone | 1 | 1989 | 65 |
Why?
| Phosphoserine | 1 | 1988 | 14 |
Why?
| Leucine | 1 | 1988 | 53 |
Why?
| Phosphotyrosine | 1 | 1988 | 26 |
Why?
| Gene Expression | 1 | 1992 | 291 |
Why?
| Signal Transduction | 1 | 1997 | 313 |
Why?
| Tyrosine | 1 | 1988 | 71 |
Why?
| Lactose | 1 | 1986 | 10 |
Why?
| Dietary Carbohydrates | 1 | 1986 | 23 |
Why?
| Cell Survival | 1 | 1988 | 230 |
Why?
| Sucrose | 1 | 1986 | 35 |
Why?
| Phosphorylation | 1 | 1988 | 224 |
Why?
| Microbial Collagenase | 1 | 1979 | 10 |
Why?
| Myocardium | 1 | 1958 | 119 |
Why?
|
|
Sparks's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
